E2F2 and osteoporosis: Further studies revealed that miR-31a-5p promotes the expression of senescence-associated markers by inhibiting E2F transcription factor 2 (E2F2) activity, which leads to increased osteoclast activity and ultimately results in osteoporosis [164].